Stromal protein periostin identified as a progression associated and prognostic biomarker in glioma via inducing an invasive and proliferative phenotype

International Journal of Oncology

Volumn 42, Issue 5, 2013, Pages 1716-1724

  Wang, Hongjun ^a   Wang, Yongzhi ^b   Jiang, Chuanlu ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Invasion; Malignant glioma; Periostin; Proliferation; Stromal protein; Survival

Indexed keywords

ANTINEOPLASTIC AGENT; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RUNX2;

ADULT; AGED; ANAPLASTIC GLIOMA; ARTICLE; ASTROCYTOMA; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER INVASION; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CELL MIGRATION; FEMALE; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PHENOTYPE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; BRAIN NEOPLASMS; CELL ADHESION MOLECULES; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; SIGNAL TRANSDUCTION; STROMAL CELLS; TUMOR MARKERS, BIOLOGICAL;

EID: 84876004117     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2013.1847     Document Type: Article

References (34)

1. Zhang J, Sarkar S and Yong VW: The chemokine stromal cell derived factor-1 (CXCL12) promotes glioma invasiveness through MT2-matrix metalloproteinase. Carcinogenesis 26: 2069-2077, 2005. (Pubitemid 41672194)
2. Wang Y, Chen L, Bao Z, et al: Inhibition of STAT3 reverses alkylator resistance through modulation of the AKT and beta-catenin signaling pathways. Oncol Rep 26: 1173-1180, 2011.
3. Malanchi I, Santamaria-Martinez A, Susanto E, et al: Interactions between cancer stem cells and their niche govern metastatic colonization. Nature 481: 85-89, 2012.
4. Contie S, Voorzanger-Rousselot N, Litvin J, Clezardin P and Garnero P: Increased expression and serum levels of the stromal cell-secreted protein periostin in breast cancer bone metastases. Int J Cancer 128: 352-360, 2011.
5. Sasaki H, Yu CY, Dai M, et al: Elevated serum periostin levels in patients with bone metastases from breast but not lung cancer. Breast Cancer Res Treat 77: 245-252, 2003. (Pubitemid 36197639)
6. Ben QW, Jin XL, Liu J, Cai X, Yuan F and Yuan YZ: Periostin, a matrix specific protein, is associated with proliferation and invasion of pancreatic cancer. Oncol Rep 25: 709-716, 2011.
7. Ruan K, Bao S and Ouyang G: The multifaceted role of periostin in tumorigenesis. Cell Mol Life Sci 66: 2219-2230, 2009.
8. Kudo Y, Ogawa I, Kitajima S, et al: Periostin promotes invasion and anchorage-independent growth in the metastatic process of head and neck cancer. Cancer Res 66: 6928-6935, 2006. (Pubitemid 44197667)
9. Siriwardena BS, Kudo Y, Ogawa I, et al: Periostin is frequently overexpressed and enhances invasion and angiogenesis in oral cancer. Br J Cancer 95: 1396-1403, 2006. (Pubitemid 44760092)
10. Erkan M, Kleeff J, Gorbachevski A, et al: Periostin creates a tumor-supportive microenvironment in the pancreas by sustaining fibrogenic stellate cell activity. Gastroenterology 132: 1447-1464, 2007. (Pubitemid 46627568)
11. Tai IT, Dai M and Chen LB: Periostin induction in tumor cell line explants and inhibition of in vitro cell growth by anti-periostin antibodies. Carcinogenesis 26: 908-915, 2005. (Pubitemid 41214319)
12. Gillan L, Matei D, Fishman DA, Gerbin CS, Karlan BY and Chang DD: Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility. Cancer Res 62: 5358-5364, 2002. (Pubitemid 35024613)
13. Shao R, Bao S, Bai X, et al: Acquired expression of periostin by human breast cancers promotes tumor angiogenesis through up-regulation of vascular endothelial growth factor receptor 2 expression. Mol Cell Biol 24: 3992-4003, 2004. (Pubitemid 38496176)
14. Zinn PO, Mahajan B, Sathyan P, et al: Radiogenomic mapping of edema/cellular invasion MRI-phenotypes in glioblastoma multiforme. PLoS One 6: e25451, 2011.
15. Gottlieb A, Varshavsky R, Linial M and Horn D: UFFizi: a generic platform for ranking informative features. BMC Bioinformatics 11: 300, 2010.
16. Mikheeva SA, Mikheev AM, Petit A, et al: TWIST1 promotes invasion through mesenchymal change in human glioblastoma. Mol Cancer 9: 194, 2010.
17. Tusher VG, Tibshirani R and Chu G: Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98: 5116-5121, 2001. (Pubitemid 32397092)
18. Huang da W, Sherman BT and Lempicki RA: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57, 2009.
19. Yan W and Shao R: Transduction of a mesenchyme-specific gene periostin into 293T cells induces cell invasive activity through epithelial-mesenchymal transformation. J Biol Chem 281: 19700-19708, 2006.
20. Claes A, Idema AJ and Wesseling P: Diffuse glioma growth: a guerilla war. Acta Neuropathol 114: 443-458, 2007. (Pubitemid 47521501)
21. Dauer DJ, Ferraro B, Song L, et al: Stat3 regulates genes common to both wound healing and cancer. Oncogene 24: 3397-3408, 2005. (Pubitemid 40756241)
22. Senft C, Priester M, Polacin M, et al: Inhibition of the JAK-2/STAT3 signaling pathway impedes the migratory and invasive potential of human glioblastoma cells. J Neurooncol 101: 393-403, 2011.
23. Stupp R, Mason WP, van den Bent MJ, et al: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987-996, 2005. (Pubitemid 40349501)
24. Giese A, Bjerkvig R, Berens ME and Westphal M: Cost of migration: invasion of malignant gliomas and implications for treatment. J Clin Oncol 21: 1624-1636, 2003. (Pubitemid 46594118)
25. Wick W, Stupp R, Beule AC, et al: A novel tool to analyze MRI recurrence patterns in glioblastoma. Neurooncology 10: 1019-1024, 2008.
26. Utispan K, Thuwajit P, Abiko Y, et al: Gene expression profiling of cholangiocarcinoma-derived fibroblast reveals alterations related to tumor progression and indicates periostin as a poor prognostic marker. Mol Cancer 9: 13, 2010.
27. Tilman G, Mattiussi M, Brasseur F, van Baren N and Decottignies A: Human periostin gene expression in normal tissues, tumors and melanoma: evidences for periostin production by both stromal and melanoma cells. Mol Cancer 6: 80, 2007.
28. Sasaki H, Dai M, Auclair D, et al: Serum level of the periostin, a homologue of an insect cell adhesion molecule, as a prognostic marker in nonsmall cell lung carcinomas. Cancer 92: 843-848, 2001. (Pubitemid 32783071)
29. Park MH and Min do S: Quercetin-induced downregulation of phospholipase D1 inhibits proliferation and invasion in U87 glioma cells. Biochem Biophys Res Commun 412: 710-715, 2011.
30. Mut M, Amos S and Hussaini IM: PKC alpha phosphorylates cytosolic NF-kappaB/p65 and PKC delta delays nuclear translocation of NF-kappaB/p65 in U1242 glioblastoma cells. Turk Neurosurg 20: 277-285, 2010.
31. Lakka SS, Gondi CS, Yanamandra N, et al: Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis. Oncogene 23: 4681-4689, 2004. (Pubitemid 38859457)
32. Kupferman ME, Fini ME, Muller WJ, Weber R, Cheng Y and Muschel RJ: Matrix metalloproteinase 9 promoter activity is induced coincident with invasion during tumor progression. Am J Pathol 157: 1777-1783, 2000.
33. Kang CS, Pu PY, Li YH, et al: An in vitro study on the suppressive effect of glioma cell growth induced by plasmid-based small interference RNA (siRNA) targeting human epidermal growth factor receptor. J Neurooncol 74: 267-273, 2005.
34. Friedberg MH, Glantz MJ, Klempner MS, Cole BF and Perides G: Specific matrix metalloproteinase profiles in the cerebrospinal fluid correlated with the presence of malignant astrocytomas, brain metastases and carcinomatous meningitis. Cancer 82: 923-930, 1998. (Pubitemid 28104173)